Statements (31)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:drug
enzyme replacement therapy |
gptkbp:activeIngredient |
gptkb:alglucosidase_alfa
|
gptkbp:approvedBy |
gptkb:FDA
gptkb:EMA 2006 |
gptkbp:ATCCode |
A16AB07
|
gptkbp:brand |
gptkb:alglucosidase_alfa
|
gptkbp:CASNumber |
339186-68-8
|
gptkbp:form |
powder for solution for infusion
|
https://www.w3.org/2000/01/rdf-schema#label |
Myozyme
|
gptkbp:indication |
lysosomal storage disorder
|
gptkbp:legalStatus |
prescription only
|
gptkbp:manufacturer |
gptkb:Sanofi_Genzyme
|
gptkbp:marketedIn |
gptkb:European_Union
gptkb:United_States |
gptkbp:mechanismOfAction |
replaces acid alpha-glucosidase
|
gptkbp:pregnancyCategory |
C (US)
|
gptkbp:routeOfAdministration |
intravenous
|
gptkbp:sideEffect |
allergic reactions
respiratory complications infusion-related reactions |
gptkbp:treatment |
gptkb:glycogen_storage_disease_type_II
|
gptkbp:UNII |
6U8Z330A7M
|
gptkbp:usedFor |
gptkb:Pompe_disease
|
gptkbp:bfsParent |
gptkb:Genzyme
gptkb:Genzyme_(2011) gptkb:Sanofi-Aventis gptkb:Sanofi_Aventis gptkb:赛诺菲 |
gptkbp:bfsLayer |
6
|